P&T COMMUNITY
 
MediMedia Managed Markets
Our
Other
Journal
Managed Care magazine
Login / Register
Join Us  Facebook  Twitter  Linked In
About P&T Journal
Contacts:
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
    Vice President, Group Publisher

Production: Mary Ellen Curry,
    Director of Production Services

Circulation: Jackie Ott, Circulation Manager


Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints


Recent Issues

February 2002

Features

Drug Shortages (4-Part Series)

Part 1: Antimicrobial Shortages

In the first article in this four-part series, Dr. Babinchak discusses the scope and consequences of antimicrobial shortages.
Timothy J. Babinchak, MD

Pharmaceutical-Approval Update

New treatments for gram-positive and gram-negative bacteria, rheumatoid arthritis, and migraine, along with a new antiviral drug for the treatment of HIV-1 infection.
Marvin M. Goldenberg, PhD

Continuing Education Credit

Oral Anticonvulsants Used in the Chronic Management of Seizure Disorders

The author provides an overview of anticonvulsants approved during the past 25 years for the treatment and management of seizures.
Gale M. Tucker, PharmD, RPh

Departments

Editorial

Beyond Bar Codes: FindtheDOT

David B. Nash, MD, MBA, Editor-in-Chief, goes beyond bar codes to “FindtheDOT.”
David B. Nash, MD, MBA

Drug News

New Drugs/Drug News

The latest information about approvals, indication changes, industry updates, and news from the FDA.

Prescription Washington

Pharmaceutical “Rules of Engagement”

Stephen Barlas discusses the forthcoming pharmaceutical “Rules of Engagement.”
Stephen Barlas

Drug Forecast

Review of Almotriptan: A 5-HT1B/1D Agonist

Review of Almotriptan: A 5-HT1B/1D agonist for the treatment of migraine.
Brooke D. Fidler, PharmD

Medication Errors

Medication Error or Professional Judgement?

Matthew Grissinger, RPh, discusses the question of who is to blame for “omission errors.”
Matthew Grissinger, RPh